Adjuvant trastuzumab for breast cancer: advent of pharmacogenetics raises many issues.
Thornton
Hazel
H
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D004992:Ethics, Medical; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D010597:Pharmacogenetics; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab